NCT00361491View on ClinicalTrials.gov

An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Depressive Disorder
Interventions
DRUG

SSR149415

Trial Locations (7)

Unknown

Sanofi-Aventis Administrative Office, Buenos Aires

Sanofi-Aventis Administrative Office, Sofia

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, Zagreb

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Moscow

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00361491 - An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter